Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial
Although these instruments have been subjected to feasibility, reliability, and validity testing, additional development and testing would be required prior to transforming the concepts reflected in the BIMS and CAM (for example, temporal orientation, recall) into fully specified measures for implementation in the LTCH QRP
Follow dosage and timing as prescribed
Compared with fasting, the peak and total plasma concentrations of LA decrease by about 30 and 20%, respectively, when LA is ingested during a meal
Hypersensitivity reactions are directly proportional to serum acetylcysteine level and commonly happens during the 1st infusion